Vesigard 15mg Tablet ER
Marketer
Cipla Ltd
Salt Composition
Darifenacin (15mg)
Overview Vesigard 15mg Tablet ER
Solifenacin succinate 15mg extended-release tablets (Vesigard equivalent) are an anticholinergic medication employed to manage overactive bladder. This treatment alleviates urinary symptoms such as frequent, urgent, and uncontrolled urination. Always adhere to your physician's prescribed dosage and duration. It may be ingested with or without food; swallow the tablet whole – avoid crushing or chewing. Discontinuing this medication prematurely can exacerbate symptoms; consult your doctor before stopping treatment. Complete the prescribed course for optimal results. Common side effects include constipation, headache, dry mouth, urinary tract infections, nausea, and dry nose. Report any persistent or bothersome side effects promptly to your doctor, who can offer strategies for managing them. Before commencing treatment, disclose all other medications and existing health conditions to your physician. Inform your doctor if you are pregnant or breastfeeding. This medication is generally unsuitable for patients with severe hepatic impairment; seek medical advice before use.
Uses of Vesigard 15mg Tablet ER
Managing overactive bladder (OAB) symptoms
Major Benefits of Vesigard 15mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vesigard 15mg Extended-Release Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Vesigard 15mg Tablet ER:
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use Vesigard 15mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The 15mg extended-release Vesigard tablet should be swallowed whole; do not damage it by chewing, crushing, or breaking. While you may consume it with or without food, consistency is key—take it at the same time each day.
How Vesigard 15mg Tablet ER works:
Extended-release Vesigard 15mg tablets are an antimuscarinic medication. Their action involves relaxing bladder muscles, thereby reducing urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Vesigard 15mg Tablet ER with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vesigard 15mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vesigard 15mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Extended-release Vesigard 15mg tablets can induce adverse reactions that might impair driving. These potential side effects include dizziness, blurred vision, insomnia, or drowsiness, potentially affecting driving skills.
KidneySAFE IF PRESCRIBED
Extended-release Vesigard 15mg tablets are considered safe for individuals with kidney conditions; no dosage modification is typically necessary. Nevertheless, disclosure of any pre-existing kidney disease to your physician is advised.
LiverCAUTION
Extended-release Vesigard 15mg tablets require careful administration for individuals with advanced hepatic impairment. Dosage modification of Vesigard 15mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Vesigard 15mg Tablet ER :
Should you forget a Vesigard 15mg Extended-Release Tablet, take it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Vesigard 15mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Good Habits | No. |
| Treatment Category | Urology |
3,018 People bought this recently